SWShihui Wei

Shihui Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shihui Wei has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Hongyang Li

    Department of Ophthalmology Beijing Friendship Hospital Capital Medical University Beijing China

    3 shared publications
  • Quangang Xu

    Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    3 shared publications
  • Hao Kang

    Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Nanping Ai

    Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Shanshan Cao

    Department of ophthalmology, the Chinese People's Liberation Army General Hospital, Beijing, China

    2 shared publications
  • Tingjun Chen

    Department of ophthalmology, the Chinese People's Liberation Army General Hospital, Beijing, China

    2 shared publications

Latest Publications

  • Open Access

    Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis

    by Hao Kang, Hongyang Li, Nanping Ai, Hongjuan Liu, Quangang Xu, Yong Tao, Shihui Wei

    Purpose: The purpose of this study was to examine the differences in immunopathogenesis based on the cytokine/chemokine profiles in myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-positive and -negative groups. Methods: We measured the levels of T-helper cell 17 (Th17) cell-related cytokines/chemokines in 74 serum samples, which were divided into four groups: healthy control (HC) group (n = 15), idiopathic demyelinating optic neuritis (IDON) group (n = 20), aquaporin 4 (AQP4)-IgG-positive optic neuritis (ON) group (n = 18), and MOG-IgG positive-ON group (n = 21). Serum IL17, IL21, IL28, IL31, CXCL1, CXCL2, CCL2, CCL11, CCL20, and LT-α were detected. Results: The serum of the MOG-IgG-positive ON patients showed an obvious elevation of Th17 cell-related cytokines/chemokines compared with that of all the MOG-IgG-negative ON patients. Serum IL17 and IL21 were significantly higher in the ON patients with MOG-IgG positive than in all the other three groups. The serum levels of IL28, IL31, CXCL1, and CCL11 were higher in the ON patients with MOG-IgG positive than in the HC group and the IDON group. The serum concentration of CCL2, CXCL2, and CCL20 in the MOG-IgG-positive and AQP4-IgG-positive group is higher than that of the HC group. No difference in serum LT-α level was found among the four groups. Adjusted multiple regression analyses showed a positive association of IL17 and IL21 levels with the serum concentration of MOG-IgG in the ON patients. Conclusion: The elevated serum level of Th17 cell-related cytokine/chemokines may play an important role in the pathogenesis of MOG-IgG-positive demyelinating ON.


  • Open Access

    Simultaneous bilateral optic neuritis in China: clinical, serological and prognostic characteristics

    by Hao Kang, Zihao Liu, Hongyang Li, Tingjun Chen, Nanping Ai, Quangang Xu, Shanshan Cao, Yong Tao, Shihui Wei

    Purpose: To analyse the clinical characteristics of simultaneous bilateral ON patients in China.Methods: This retrospective study was done on 51 primary bilateral ON patients between April 2008 and July 2016 at the Chinese People's Liberation Army General Hospital. Fifty eight primary unilateral ON patients formed the control group. Demographic data, clinical course, serum autoantibody status, connective tissue disorders, magnetic resonance imaging and visual functions were compared.Results: The mean age at disease onset in the bilateral group was younger than that of the unilateral group (p = 0.001). Cerebrospinal fluid (CSF) total cell count and CSF total protein were significantly higher in the bilateral group (p = 0.001, p = 0.025). Aquaporin‐4 (AQP4) antibodies were detected in 39% and 21% of the bilateral and unilateral patients, respectively (p = 0.03). Twenty two percent of the bilateral patients fulfilled the diagnosis of neuromyelitis optica (NMO); 7% in the unilateral group did so (p = 0.03). Serum autoantibodies (ANA, SSA, SSB, etc.) were found in 49% of the bilateral patients and 29% of the unilateral patients (p = 0.035). After treatment, the bilateral patients were significantly more prone to severe visual disability eventually than their unilateral counterparts (p = 0.002). Patients with MOG‐IgG (myelin oligodendrocyte glycoprotein‐IgG) represented 26% of the patients negative for AQP4‐IgG. Myelin oligodendrocyte glycoprotein‐IgG (MOG‐IgG) sero‐positive patients were more likely to recover than the other patients (p < 0.001).Conclusion: Simultaneous bilateral ON is a severe disorder closely related to serum AQP4‐IgG and MOG‐IgG, which are more likely to involve younger people and incur severe visual disability eventually. Myelin oligodendrocyte glycoprotein‐IgG (MOG‐IgG) sero‐positive patients have higher risk of ON relapses and better visual prognosis.


  • Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis

    by Hao Kang, Tingjun Chen, Hongyang Li, Quangang Xu, Shanshan Cao, Shihui Wei

    The objective is to assess the frequency of AQP4-Ab in Chinese patients with optic neuritis (ON) and to investigate the prognostic implications of AQP4-Ab seropositivity in such patients. The presence of aquaporin-4 (AQP4) antibodies in human AQP4-transfected cells was determined by indirect immunofluorescence, and the diagnostic and prognostic relevance of AQP4 antibodies in 215 Chinese patients with optic neuritis was evaluated. The patients were enrolled from the Chinese People’s Liberation Army General Hospital (PLAGH) and followed up to 1–228 months. Kaplan–Meier survival analysis was used to investigate the visual outcomes and prognostic characteristics of 70 patients who were aquaporin-4 antibody seropositive, and altogether 115 eyes were involved. AQP4-Ab was detectable in 70/215 (32.6%) patients with acute monosymptomatic optic neuritis. These AQP4-Ab seropositive patients were diagnosed as sufferers of neuromyelitis optica (NMO) (n = 10), NMO spectrum disease (NMOSD) (n = 41), multiple sclerosis (MS) (n = 1), and acute optic neuritis (AON) (n = 18). Moreover, AQP4-Ab levels did not vary between seropositive AON and NMO-ON and did not correlate with disease severity. Finally, the male gender, older age at onset, number of relapses, concomitant autoimmune antibodies, and optic lesions in magnetic resonance imaging (MRI) were associated with the AQP4-Ab seropositive status and the risk of developing permanent visual disability. Acute optic neuritis has a higher incidence of anti-aquaporin-4 antibody in China than in Western countries, and AQP4 antibody is a sensitive and specific biomarker for discriminating NMO-ON from other types of optic neuritis during the early stage of the disease course.